Mao Lin He

Dr. Mao Lin He


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 April 2023 in iScience
Verified
Journal Article
Open access
HHHao Hu
Hao Hu
JYJunxu Yang
Junxu Yang
YZYanping Zhong
Yanping Zhong
JWJiawei Wang
Jiawei Wang
JCJinhong Cai
Jinhong Cai
LZLi Zheng
Li Zheng
Excessive reactive oxygen species (ROS) in joints could lead to gradual degeneration of the extracellular matrix (ECM) and apoptosis of chondrocytes, contributing to the occurrence and development of osteoarthritis (OA). Mimicking natural enzymes, polydopamine (PDA)-based nanozymes showed great potential in treating various inflammatory diseases. In this work, PDA loaded with ultra-small palladium (PDA-Pd) nanoparticles (NPs) was employed to scavenge ROS for OA therapy. As a result, PDA-Pd effectively declined the intracellular ROS levels and exhibited efficient antioxidative and anti-inflammatory capacity with good biocompatibility in IL-1β stimulated chondrocytes. Significantly, assisted with near-infrared (NIR) irradiation, its therapeutic effect was further enhanced. Further, NIR-stimulated PDA-Pd suppressed the progression of OA after intra-articular injection in the OA rat model. With favorable biocompatibility, PDA-Pd exhibits efficient antioxidative and anti-inflammatory capacity, leading to the alleviation of OA in rats. Our findings may provide new insights into the treatment of various ROS-induced inflammatory diseases.

6 April 2023 in Frontiers in Immunology
Verified
Journal Article
Open access
HTHaijun Tang
Haijun Tang
SLShangyu Liu
Shangyu Liu
XLXiaoting Luo
Xiaoting Luo
YSYu Sun
Yu Sun
XLXiangde Li
Xiangde Li
MHMao Lin He
Mao Lin He
Background: Tumor infiltrating lymphocytes (TILs), the main component in the tumor microenvironment, play a critical role in the antitumor immune response. Few studies have developed a prognostic model based on TILs in osteosarcoma.Methods: ScRNA-seq data was obtained from our previous research and bulk RNA transcriptome data was from TARGET database. WGCNA was used to obtain the immune-related gene modules. Subsequently, we applied LASSO regression analysis and SVM algorithm to construct a prognostic model based on TILs marker genes. What’s more, the prognostic model was verified by external datasets and experiment in vitro. Results: Eleven cell clusters and 2044 TILs marker genes were identified. WGCNA results showed that 545 TILs marker genes were the most strongly related with immune. Subsequently, a risk model including 5 genes was developed. We found that the survival rate was higher in the low-risk group and the risk model could be used as an independent prognostic factor. Meanwhile, high-risk patients had a lower abundance of immune cell infiltration and many immune checkpoint genes were highly expressed in the low-risk group. The prognostic model was also demonstrated to be a good predictive capacity in external datasets. The result of RT-qPCR indicated that these 5 genes have differential expression which accorded with the predicting outcomes.Conclusions: This study developed a new molecular signature based on TILs marker genes, which is very effective in predicting OS prognosis and immunotherapy response.

16 August 2024 in Frontiers in Bioscience-Landmark
Verified
Journal Article
Open access
PDF file
SWShengyong Wang
Shengyong Wang
QZQuan Zhou
Quan Zhou
SYSheng Yan
Sheng Yan
CLChang Liu
Chang Liu
FLFujun Li
Fujun Li
MHMao Lin He
Mao Lin He
Background: Glioblastoma (GBM) is a highly aggressive and fast-growing brain tumor, characterized by rapid progression, a very poor prognosis, and a high likelihood of recurrence. Thus, effective new therapeutic targets are urgently needed. Transmembrane proteins (TMEMs) have pro-cancer effects on multiple cancer types, but the mechanisms underlying the effects of TMEM17, particularly its role in GBM, remain unclear. Methods: We conducted bioinformatics analyses and immunohistochemistry to evaluate the role of TMEM17 in a variety of cancer types. Functional assays were conducted included the Cell Counting Kit-8 assay, annexin V-FITC/PI double staining, 5-ethynyl-2′-deoxyuridine (EdU) incorporation assay, wound healing assay, transwell invasion assay, and dual luciferase assay. Results: We found that TMEM17 is associated with a poor prognosis in GBM. Prognostic analyses confirmed that high TMEM17 expression predicted poorer survival, establishing its significance as an independent prognostic factor. Functional assays demonstrated that silencing TMEM17 in GBM cell lines inhibited proliferation and invasion, and induced apoptosis, underscoring its role in tumor aggressiveness. From a mechanistic perspective, we discovered that the Ying Yang 1 (YY1) transcription factor can bind to the promoter of TMEM17, regulating its upregulation. Regarding downstream mechanisms, knocking down TMEM17 inhibited the phosphoinositide 3-kinase/AKT pathway. These findings suggest that TMEM17 plays a significant role in GBM and may be a potential therapeutic target for this cancer. Conclusion: These data prove that TMEM17 plays a key role in the regulation of GBM and has great potential as a clinical therapeutic target for GBM.

13 April 2025 in npj Precision Oncology
Verified
Journal Article
Open access
PDF file
HTHaijun Tang
Haijun Tang
YCYangjie Cai
Yangjie Cai
MYMingxiu Yang
Mingxiu Yang
STShengping Tang
Shengping Tang
QHQian Huang
Qian Huang
SLShijie Liao
Shijie Liao
Osteosarcoma, the most common primary malignant bone tumor in children and adolescents, is highly aggressive and prone to metastasis. Endothelial cells (ECs) are involved in angiogenesis and play a key role in promoting the metastasis of tumor. However, research on tip-like ECs within osteosarcoma was extremely rare. In this study, a single-cell atlas of ECs was constructed using single-cell transcriptomic data. It was found that tip-like ECs were abundant in the primary tumors and metastatic foci. Gene sets score analysis indicated their enrichment in pathways associated with angiogenesis and metastasis. What’s more, MCAM was highly expressed in tip-like ECs and was likely to promote the metastasis of osteosarcoma. MCAM was also found to be highly expressed in the ECs of metastatic lymph nodes when compared to normal lymph node samples. Meanwhile, spatial transcriptomics data confirmed the presence of MCAM-positive ECs in metastatic lymph node, closely localized to osteoblasts. In vitro assays, including qRT-PCR, tube formation, and immunofluorescence, validated the role of the MCAM gene in promoting angiogenesis. In conclusion, tip-like ECs may promote tumor metastasis by enhancing angiogenesis. MCAM was a functional gene for tip-like ECs and could serve as a target for the treatment of osteosarcoma.

19 November 2025 in Journal of Orthopaedic Surgery and Research
Verified
Journal Article
Open access
PDF file
SLSanmao Liu
Sanmao Liu
YSYu Sun
Yu Sun
YMYunan Man
Yunan Man
MHMao Lin He
Mao Lin He
PHPiwei Huang
Piwei Huang
This meta-analysis investigates the prevalence and risk factors for new vertebral compression fractures (NVCF) following percutaneous vertebral augmentation (PVA) in patients with osteoporotic vertebral compression fractures (OVCF). We searched PubMed, Cochrane Library, Embase, and Web of Science (up to June 2025) and screened case–control and cohort studies that utilized multivariate logistic regression analysis to examine the prevalence and risk factors of NVCF after PVA in OVCF patients. The meta-analysis was performed according to the PRISMA guidelines. After data extraction, STATA 15.0 was used to calculate the pooled odds ratio (OR) and 95% confidence interval (CI). This meta-analysis included 18 studies involving 7,743 patients, of whom 1,336 developed NVCF postoperatively, with a prevalence of 17.25%. The meta-analysis revealed that the risk factors for new fractures after PVA in OVCF patients were associated with Gender [OR = 1.99, 95%CI (1.50, 2.64), P < 0.001], Age [OR = 1.09, 95%CI (1.02, 1.17), P = 0.01], Bone mineral density (BMD) [OR = 0.74, 95%CI (0.63, 0.86), P < 0.001],Bone cement disc leakage [OR = 2.94, 95%CI (1.64, 5.28), P < 0.001], Lack of anti-osteoporosis treatment [OR = 2.93, 95%CI (2.14, 4.01), P < 0.001], Thoracolumbar junction (TL junction) [OR = 3.50, 95%CI (2.06, 5.93), P < 0.001], Hounsfield unit value (HU value) [OR = 0.96, 95%CI (0.95, 0.97), P < 0.001], Use of steroids [OR = 3.94, 95%CI (2.16, 7.21), P < 0.001], Number of initial fractures [OR = 2.21, 95%CI (1.17, 4.14), P = 0.01], Multiple vertebral fractures [OR = 1.71, 95%CI (1.14, 2.57), P = 0.01], Fracture history [OR = 7.72, 95%CI (3.09, 9.30), P < 0.001], Smoking [OR = 1.62, 95%CI (1.20, 2.19), P < 0.001], and Diabetes [OR = 1.98, 95%CI (1.50, 2.61), P < 0.001]. However, no association was found with Body mass index (BMI), Bone cement leakage, and Shape of bone cement. This study confirms that NVCF following PVA for OVCF is multifactorial, with most risk factors identifiable preoperatively. The clinical value of this knowledge lies in its application to guide postoperative prevention, thereby optimizing management quality through personalized follow-up and intervention.

26 November 2022 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Open access
LXLong Xie
Long Xie
WYWenhua Yin
Wenhua Yin
FTFuxing Tang
Fuxing Tang
MHMao Lin He
Mao Lin He
To investigate the possible functions of TERT in pan-cancer and OS. First, differential TERT gene expression analysis was conducted using multi-omics data integrative analyses, including differential expression, prognosis, the correlation between infiltrating inflammatory immune cells, and mutation in pan-cancer. Furthermore, differential TERT gene expression analysis was conducted using mRNA expression profiles related to OS based on the GEO Datasets. Various differentially expressed genes were chosen based on a fitness threshold for further investigations. Finally, the function of the TERT gene was assessed in OS cells, including cellular proliferation, migration, and metastasis. Pan-cancer research demonstrated that variable expression of TERT was not only associated with numerous types of human cancer but was also intimately linked to DNA methylation. Bioinformatic investigation revealed a link between the differential expression of TERT with immune cell infiltration in the tumor microenvironment (TME). In vitro studies indicated that inhibition of TERT decreased OS cell proliferation, motility, and metastasis. TERT may serve as a useful genomic biomarker for the diagnosis and prediction of pan-cancer and as a prospective therapeutic target for the treatment of OS.